JP2022523554A5 - - Google Patents

Info

Publication number
JP2022523554A5
JP2022523554A5 JP2021552600A JP2021552600A JP2022523554A5 JP 2022523554 A5 JP2022523554 A5 JP 2022523554A5 JP 2021552600 A JP2021552600 A JP 2021552600A JP 2021552600 A JP2021552600 A JP 2021552600A JP 2022523554 A5 JP2022523554 A5 JP 2022523554A5
Authority
JP
Japan
Application number
JP2021552600A
Other languages
Japanese (ja)
Other versions
JP2022523554A (ja
JPWO2020178739A5 (https=
JP7561133B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2020/051808 external-priority patent/WO2020178739A1/en
Publication of JP2022523554A publication Critical patent/JP2022523554A/ja
Publication of JP2022523554A5 publication Critical patent/JP2022523554A5/ja
Publication of JPWO2020178739A5 publication Critical patent/JPWO2020178739A5/ja
Priority to JP2024163997A priority Critical patent/JP2025000725A/ja
Application granted granted Critical
Publication of JP7561133B2 publication Critical patent/JP7561133B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021552600A 2019-03-04 2020-03-03 T細胞受容体及びその使用方法 Active JP7561133B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024163997A JP2025000725A (ja) 2019-03-04 2024-09-20 T細胞受容体及びその使用方法

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962813642P 2019-03-04 2019-03-04
US62/813,642 2019-03-04
PCT/IB2020/051808 WO2020178739A1 (en) 2019-03-04 2020-03-03 T cell receptors and methods of use thereof

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024163997A Division JP2025000725A (ja) 2019-03-04 2024-09-20 T細胞受容体及びその使用方法

Publications (4)

Publication Number Publication Date
JP2022523554A JP2022523554A (ja) 2022-04-25
JP2022523554A5 true JP2022523554A5 (https=) 2023-03-13
JPWO2020178739A5 JPWO2020178739A5 (https=) 2023-03-13
JP7561133B2 JP7561133B2 (ja) 2024-10-03

Family

ID=72337709

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021552600A Active JP7561133B2 (ja) 2019-03-04 2020-03-03 T細胞受容体及びその使用方法
JP2024163997A Pending JP2025000725A (ja) 2019-03-04 2024-09-20 T細胞受容体及びその使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024163997A Pending JP2025000725A (ja) 2019-03-04 2024-09-20 T細胞受容体及びその使用方法

Country Status (13)

Country Link
US (1) US20220152104A1 (https=)
EP (1) EP3935174A4 (https=)
JP (2) JP7561133B2 (https=)
KR (1) KR20210149050A (https=)
CN (1) CN113906141B (https=)
AU (1) AU2020231927A1 (https=)
BR (1) BR112021017464A2 (https=)
CA (1) CA3132238A1 (https=)
IL (1) IL286037A (https=)
MX (1) MX2021010543A (https=)
SG (1) SG11202109589VA (https=)
TW (1) TWI872051B (https=)
WO (1) WO2020178739A1 (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2020231927A1 (en) * 2019-03-04 2021-09-30 University Health Network T cell receptors and methods of use thereof
JP7748284B2 (ja) 2019-03-04 2025-10-02 ユニバーシティー ヘルス ネットワーク T細胞受容体及びその使用方法
MX2021010541A (es) 2019-03-04 2021-12-15 Univ Health Network Receptores de linfocitos t y metodos de uso de estos.
CN113795586B (zh) 2019-03-25 2026-03-27 大学健康网络 T细胞受体及其使用方法
CA3233809A1 (en) * 2021-10-06 2023-04-13 University Health Network Modified immune cells and methods of use thereof
AU2024269870A1 (en) * 2023-05-05 2025-11-20 Board Of Regents, The University Of Texas System Multi-receptor natural killer cells

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9051391B2 (en) * 2007-06-11 2015-06-09 Takara Bio Inc. Method for expression of specific gene
ES2635335T3 (es) * 2010-09-20 2017-10-03 Biontech Cell & Gene Therapies Gmbh Receptores de células T específicos de antígeno y epítopos de células T
WO2014207708A2 (en) * 2013-06-28 2014-12-31 Auckland Uniservices Limited Amino acid and peptide conjugates and conjugation process
KR101503341B1 (ko) * 2014-03-12 2015-03-18 국립암센터 자가암항원 특이적 cd8+ t 세포의 분리 및 증식방법
WO2017076308A1 (zh) * 2015-11-04 2017-05-11 广州市香雪制药股份有限公司 识别ny-eso-1抗原短肽的tcr
WO2017120428A2 (en) * 2016-01-06 2017-07-13 Health Research, Inc. Compositions and libraries comprising recombinant t-cell receptors and methods of using recombinant t-cell receptors
AU2020231927A1 (en) * 2019-03-04 2021-09-30 University Health Network T cell receptors and methods of use thereof

Similar Documents

Publication Publication Date Title
BR112023005462A2 (https=)
BR112023012656A2 (https=)
BR112021014123A2 (https=)
JP2022523554A5 (https=)
BR112023009656A2 (https=)
BR112022009896A2 (https=)
JP2022523553A5 (https=)
BR112021017747A2 (https=)
BR112022024743A2 (https=)
BR112022026905A2 (https=)
BR112023011738A2 (https=)
BR112023004146A2 (https=)
BR112023006729A2 (https=)
BR102021018859A2 (https=)
BR102021015500A2 (https=)
BR112023016292A2 (https=)
BR112023011610A2 (https=)
BR112023011539A2 (https=)
BR112023008976A2 (https=)
BR102021020147A2 (https=)
BR102021018926A2 (https=)
BR102021018167A2 (https=)
BR102021017576A2 (https=)
BR102021016837A2 (https=)
BR102021016551A2 (https=)